New York Times journalists had to plan carefully for an Oval Office conversation with a president who dominates discourse and makes false claims. By Seth Carlson and Mike Abrams Doug Mills, winner of ...
US Supreme Court to hear 'skinny label' patent fight involving Amarin The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback